lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Male infertility - clinical fact sheet and MCQ

11 March 2025 - Medcast Medical Education Team

Fast_Track_CPD_Tag2.png

Overview

Male factor infertility contributes to approximately 50% of cases where couples experience difficulty conceiving. Of these, about 30% of cases are solely attributable to male infertility, and 20% are a combination of male and female factors.1

Infertility is defined as the inability to achieve pregnancy after 12 months of regular, unprotected sexual intercourse. It can lead to significant stress, both to the individual and in the relationship.1

Diagnosis of male infertility

The causes of male infertility are numerous, but in up to 40% of cases, the aetiology is undetermined. Male infertility may be due to:1

  • pre-testicular causes: hypogonadotropic hypogonadism (eg, Kallman syndrome, for which symptoms include delayed puberty and an impaired sense of smell), hyperprolactinaemia (eg from a prolactinoma)

  • testicular causes (eg, testicular cancer, genetic sperm abnormalities, infection, and injury)

    • antisperm antibodies (ASA) result from a breakdown of the blood-testis barrier from injury or illness2

    • ASA may impair sperm function, but not all ASA will cause subfertility2

    • sperm agglutination on laboratory testing may indicate ASA2

  • post-testicular (eg, coital problems, retrograde ejaculation, injury or congenital absence of the vas deferens, Young’s syndrome (triad of bronchiectasis, chronic rhinosinusitis, and vas deferens obstruction))

When couples present with infertility, a comprehensive evaluation of male infertility is essential, and should be conducted concurrently with the female partner's assessment. This evaluation includes a detailed history, physical examination, and laboratory investigations as necessary.

1. History

Key aspects to cover in the history include:1,3

  • reproductive history: age of both partners, previous pregnancies, duration of attempts to conceive, and sexual practices, such as frequency, use of fertility-safe lubrication, and timing of intercourse with ovulation.

  • medical history: childhood illnesses (eg, mumps), undescended testes, testicular torsion, systemic diseases (eg, diabetes), infections (eg, sexually transmissible infections), trauma, surgery to the reproductive organs or nearby structures, and exposure to gonadotoxins (eg, chemotherapy)

  • potentially modifiable factors: use of tobacco, alcohol, recreational drugs, and exposure to environmental toxins (eg, pesticides)

2. Physical examination

The physical examination for male infertility should assess:3

  • general appearance: secondary sexual characteristics, virilisation, and body habitus

  • genital examination: testicular size as measured with an orchidometer, position, and assessment of the scrotum and penis

3. Additional investigations3
  • semen analysis is the primary investigation for assessing male infertility. Instruct sexual abstinence for 2–7 days prior to sample collection

    • if the initial analysis is abnormal, repeat the test six weeks later, to ensure that the abnormality was not transitory. Abnormal results warrant referral to a male reproductive specialist

  • hormonal assessment is recommended for all men with atrophic testes, sperm concentration and/or total sperm count below the normal limit, or who have indications of androgen deficiency:

    • serum testosterone

    • serum hormone binding globulin

    • follicle-stimulating hormone (FSH)

    • luteinising hormone (LH) 

    • prolactin

  • normal ranges for semen analysis and reference ranges for endocrine assessment can be found here

  • scrotal ultrasound is not recommended for the initial stage of investigations

  • if specialist referral is indicated, further testing may be performed, including testicular biopsy, post-ejaculatory urine analysis, genetic testing, and anti-sperm antibodies1

Management of male infertility

Management strategies depend on the identified cause of infertility and may include lifestyle modifications, medical treatments, surgical interventions, or assisted reproductive technologies (ART).

1. Behavioural modifications

General practitioners play a pivotal role in educating patients about modifiable factors that can impact fertility. Recommendations include:

  • cessation of smoking: smoking, including e-cigarettes, is associated with reduced sperm quality1,4

  • cessation of certain drugs: medicinal and recreational drugs can reduce fertility, including cannabis and opioids1

  • limiting alcohol consumption: excessive alcohol intake can impair spermatogenesis

  • weight management: obesity is linked to decreased testosterone levels, sexual dysfunction, and comorbidities such as diabetes, increasing the risk of infertility1,5

  • avoiding exposure to environmental hazards: heat (particularly to the scrotal area), pesticides, heavy metals, vibration, and ionising radiation can impact male fertility1

Male patients should be counselled against using testosterone supplements; as although they may promote sexual function, excessive testosterone has negative effects on fertility.6

2. Medical treatments

Consider referral either immediately or after performing basic infertility testing as specific medical treatments may be available for certain cases of male factor infertility, such as:1

  • hypogonadotropic hypogonadism: may be managed with dopamine agonists, cessation of medications that interfere with normal prolactin production, or administration of gonadotropins

  • varicocele: surgical ligation or embolisation in patients with clinically evident variocele and semen parameters outside normal limits may improve conception rates

  • retrograde ejaculation: pseudoephedrine may help to close the bladder neck

  • anejaculation: may require neurostimulation 

  • ejaculatory duct obstruction: transurethral resection of the duct to promote normal sperm transport and ejaculation

Where treatment or reversal of male factor infertility is unsuccessful or not feasible, referral for assisted reproductive technologies may be considered:3

  • intrauterine insemination (IUI): sperm is directly inserted into the uterus to facilitate fertilisation

  • in vitro fertilisation (IVF): eggs are fertilised with sperm in a laboratory setting, and resulting embryos are transferred to the uterus

  • intracytoplasmic sperm injection (ICSI): a single sperm is injected directly into an egg, often used in cases of severe male infertility

  • complete azoospermia will require donor insemination

For couples suffering from significant distress or relationship tension due to infertility, consider referring for psychologist or counsellor support.3

References

  1. Katz DJ, Teloken P, Shoshany O. Male infertility - The other side of the equation. AFP. 2018;46(9):641-646.

  2. Gupta S, Sharma R, Agarwal A, et al. Antisperm Antibody Testing: A Comprehensive Review of Its Role in the Management of Immunological Male Infertility and Results of a Global Survey of Clinical Practices. World J Mens Health. 2022;40(3):380-398. doi: 10.5534/wjmh.210164.  

  3. Healthy Male. Male infertility. 2024. (last accessed February 2025). 

  4. Montjean D, Godin Pagé MH, Bélanger MC, Benkhalifa M, Miron P. An Overview of E-Cigarette Impact on Reproductive Health. Life (Basel). 2023 Mar 18;13(3):827. doi: 10.3390/life13030827.

  5. Ameratunga D, Gebeh A, Amoako A. Obesity and male infertility. Best Pract Res Clin Obstet Gynaecol. 2023; 102393.

  6. Patel AS, Leong JY, Ramos L, Ramasamy R. Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility. World J Mens Health. 2019 Jan;37(1):45-54. doi: 10.5534/wjmh.180036. 

 

Claim your CPD

After reading the clinical summary above and reviewing the references, complete the quiz to gain 30 minutes of EA CPD and 30 minutes of RP CPD. 

You can either self-report CPD to your CPD home, or Medcast will track your learning via your personal CPD Tracker and you can download and report these points once a year. See our CPD Tracker FAQ

Registered users only

Log in or sign up for a free Medcast account to continue.

 

Medcast Medical Education Team
Medcast Medical Education Team

The Medcast medical education team is a group of highly experienced, practicing GPs, health professionals and medical writers.

Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Related News
Obesity/overweight in adults - clinical fact sheet and MCQ

Medcast Medical Education Team

Brand icon

The prevalence of patients living with obesity/overweight is increasing in Australia. This FastTrack fact sheet equips GPs to provide evidence-based care in primary practice according to the most recent Australian guidelines. 30mins each of RP and EA CPD available with the quiz.

10 mins READ
A practical guide to veteran care coordination in general practice

Dr Catherine Eltringham

Brand icon

Learn how your general practice can support veteran patients through the Coordinated Veterans’ Care (CVC) Program. This step-by-step guide covers eligibility, care planning, team roles and DVA claiming—helping GPs and nurses deliver structured, patient-centred care for veterans with chronic or mental health conditions.

10 mins READ
Coeliac disease - clinical fact sheet and MCQ

Medcast Medical Education Team

Brand icon

About 80% of people with coeliac disease are unaware of their condition. Without appropriate management, coeliac disease can cause infertility, osteoporosis, an increased risk of intestinal lymphoma, and more. This FastTrack fact sheet will update your knowledge on the diagnosis and management of coeliac disease. Earn 30min RP and 30mins EA CPD with the quiz.

10 mins READ